Protocol number BAN2401-G000-303: AHEAD 3-45 Study: A Placebo-Controlled, Double-Blind, Parallel-Treatment Arm, 216 Week Study to Evaluate Efficacy and Safety of Treatment With BAN2401 in Subject01/01/2020 - 12/31/2024 (PI of Sub-Project / SP)
University of Southern California Eisai, Inc
Clarifying the Role Played by Microglia and Astrocyte Activation in Veterans with Gulf War Illness Using Positron Emission Tomography (PET)09/30/2019 - 09/29/2024 (PI of Sub-Project / SP)
PI:
Kimberly A Sullivan, PhDDepartment of Defense/Army Medical Research Acquisition Activity
The A45 Study: Combination anti-amyloid therapy for preclinical Alzheimer's disease09/30/2019 - 05/31/2024 (PI of Sub-Project / SP)
University of Southern California NIH NIA1R01AG061848-01
The A3 Study: Ante-Amyloid prevention of Alzheimer's disease06/01/2019 - 04/30/2024 (PI of Sub-Project / SP)
University of Southern California NIH NIA5R01AG054029-02
Assessing the perivascular clearance of brain debris in familial and sporadic Alzheimer's disease09/01/2020 - 01/31/2023 (Subcontract PI)
The Brigham and Women's Hospital, Inc. BrightFocus Fdn
Alzheimer's Disease Neuroimaging Initiative 3 (ADNI3)09/15/2016 - 07/31/2022 (Subcontract PI)
University of Southern California NIH NIA2U19AG024904-11
ADNI-DOD-TAU, Effects of Traumatic Brain Injury and Post-Traumatic Stress Disorder and Alzheimer's Disease on Brain Tau in Vietnam Veterans using ADNI09/22/2016 - 09/21/2021 (Subcontract PI)
University of Southern California DOD Army Med Resrch
Vielight Neuro RX Gamma Photobiomodulation Device for Moderate to Severe Alzheimer's Disease04/30/2019 - 04/30/2021 (PI)
Vielight Inc.
Human Neurobiology Laboratory Support Contract with Pfizer01/01/2014 - 12/31/2018 (Co-Investigator of Sub-Project / SP)
PI:
Kevin C. Thomas, PhDPfizer, Inc.
Alzheimer's Disease Neuroimaging Initiative 2 (ADNI2)08/24/2015 - 03/31/2018 (Subcontract PI)
University of Southern California NIH NIA5U01AG024904-10
Showing 10 of 14 results.
Show All Results
National Emerging Infectious Diseases Laboratories Operations06/20/2012 - 07/31/2014 (Sub-Project Level Key Person)
PI:
John R. Murphy, PhDNIH/National Institute of Allergy & Infectious Diseases3UC7AI070088-05S3
Neurobiological Consequences of Hypertension and Age03/01/2000 - 02/28/2010 (Co-PI)
NIH/National Institute on Aging5 R37 AG17609 10
Age-Related Changes of Cognition in Health and Disease08/01/2002 - 07/31/2007 (PI)
Massachusetts General Hospital NIH NIA
A Primate Model of Hypertensive Cerebrovascular09/30/2002 - 08/31/2004 (PI)
NIH/National Institute on Aging1 R03 AG21315 01